| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2025―Dec―06 |
A single extracellular vesicle-based platform supporting both RBD protein and mRNA vaccination against SARS-CoV-2 |
Jihwa Chung, Kyoung Hwa Kim, Shung Hyun An, DaeHo Bae, Hyo Kyeong Kim, Yujeong Choi, Jae Hwan Kim, Kihwan Kwon, Seok-Hyun Kim |
| 2 |
[GO] |
2025―Nov―01 |
Gut-initiated mucosal and systemic immunity against SARS-CoV-2 via an oral hyaluronic acid/chitosan vaccine coacervate |
Shunyi Li, Shengyuan Huo, Wanru Zheng, Shipo Wu, Yi Chen, Zhe Zhang, Busen Wang, Zhenghao Zhao, Nan Huo, Jinghan Xu, Tianyu Liu, Jianglan Long, Xiaohong Song, Jinlong Zhang, Junyan Dan, Mengyao Zhang, Lihua Hou |
| 3 |
[GO] |
2025―Sep―25 |
Development of a dissolving microneedle patch for transdermal delivery of SARS-CoV-2 mRNA vaccine with enhanced stability and immunogenicity |
Zequn Tang, Tong Su, Ting Jiang, Jiayi Hu, Daiyan Chen, Xi Li, Jing Lu, Jinzhong Lin, Teng Shen |
| 4 |
[GO] |
2025―Jul―02 |
A multivalent 9-O-acetylated sialic acid-conjugated bacteriophage platform for antiviral and immunomodulatory therapy for human coronavirus OC43 |
Palaniyandi Muthukutty, Jinhyo Chung, Sehoon Kim, Hwa Young Kim, Sang Hyun Lee, Yewon Kim, Woo-Jae Chung, So Young Yoo |
| 5 |
[GO] |
2025―Jun―09 |
Lyophilized SARS-CoV-2 self-amplifying RNA vaccines for microneedle Array patch delivery |
Madison M. Driskill, Ian A. Coates, Paul J. Hurst, Netra U. Rajesh, Maria T. Dulay, Robert M. Waymouth, Wataru Akahata, Kenta Matsuda, Jonathan F. Smith, Gunilla B. Jacobson, Jillian L. Perry, Shaomin Tian, Joseph M. DeSimone |
| 6 |
[GO] |
2025―Apr―25 |
A T7 autogene-mediated DNA vaccine platform for SARS-CoV-2: Overcoming DNA vaccine limitations with enhanced spike mRNA production |
Sang Won Cho, Sang Chul Shin, Yunju Nam, Hyung Jun Ahn |
| 7 |
[GO] |
2025―Apr―18 |
Lipid nanoparticles target neutrophils to reduce SARS-CoV-2-induced lung injury and inflammation |
Ha Eun Shin, Stefanos Giannakopoulos, Joo Dong Park, Hye Jung Jang, Chun Gwon Park, Sean V. Murphy, Juwon Park, Saguna Verma, Wooram Park |
| 8 |
[GO] |
2025―Mar―31 |
On the adjuvanticity of hyaluronan: The case of a SARS-CoV-2 vaccine |
Anna Dalla Pietà, Beatrice Genova, Alessandro Penna, Alessandro Sinigaglia, Stefania Vogiatzis, Luisa Barzon, Matteo Pagliari, Francesco Bonfante, Filippo Torrigiani, Tomasoni Sofia, Ranieri Verin, Anna Tosi, Debora Carpanese, Roberta Sommaggio, Vito Barbieri, Silvia Dalla Santa, Gaia Zuccolotto, Antonella Grigoletto, Gianfranco Pasut, Antonio Rosato |
| 9 |
[GO] |
2025―Jan―24 |
Intranasal liposomal remdesivir induces SARS-CoV-2 clearance in K18-hACE2 mice and ensures survival |
Sabrina Mendes, Lays Cordeiro Guimarães, Leonardo Camilo de Oliveira, Pedro Augusto Carvalho Costa, Natália Jordana Alves da Silva, Gabriel Silva Alves Pessim Pereira, Clara Couto Fernandez, Maria Marta Figueiredo, Robson Augusto Souza dos Santos, Mauro Martins Teixeira, Vivian Vasconcelos Costa, Pedro Pires Goulart Guimarães, Frédéric Frézard |
| 10 |
[GO] |
2024―Dec―16 |
Enhancing protective immunity against SARS-CoV-2 with a self-amplifying RNA lipid nanoparticle vaccine |
Guibin Lin, Yan-Lai Tang, Zhengqiang Fu, Runjun Chen, Yan Liu, Zhanyan Liu, Xueli Kuang, Jing Sun, Jincun Zhao, Yuan Zhang |
| 11 |
[GO] |
2024―Nov―17 |
Preclinical development of lyophilized self-replicating RNA vaccines for COVID-19 and malaria with improved long-term thermostability |
Gaurav K. Gulati, Adrian C. Simpson, Zachary MacMillen, Kyle Krieger, Shibbu Sharma, Jesse H. Erasmus, Steven G. Reed, James W. Davie, Marion Avril, Amit P. Khandhar |
| 12 |
[GO] |
2024―Jan―20 |
Protein subunit vaccines: Promising frontiers against COVID-19 |
Vivek P. Chavda, Eswara Naga Hanuma Kumar Ghali, Pankti C. Balar, Subhash C. Chauhan, Nikita Tiwari, Somanshi Shukla, Mansi Athalye, Vandana Patravale, Vasso Apostolopoulos, Murali M. Yallapu |
| 13 |
[GO] |
2024―Jan―11 |
An inoculation site-retained mRNA vaccine induces robust immune responses against SARS-CoV-2 variants |
Lei Huang, Fanfan Zhao, Muye He, Yi Fang, Xiaoping Ma, Shuaiyao Lu, Entao Li, Hui Xiao, Hanfei Zhu, Xueli Wang, Siyuan Tang, Bo Yu, Jie Wang, Dong Zhao, Chao Wang, Hangwen Li, Yuwei Gao, Xiaozhong Peng, Haifa Shen |
| 14 |
[GO] |
2023―Nov―22 |
Nanomedicine approaches against SARS-CoV-2 and variants |
Han Zhang, Yanbin Liu, Zhuang Liu |
| 15 |
[GO] |
2023―Nov―16 |
Drug repurposing for the treatment of COVID-19: Targeting nafamostat to the lungs by a liposomal delivery system |
Philipp Reus, Hadar Guthmann, Nadja Uhlig, Majd Agbaria, Leila Issmail, Valentina Eberlein, Mirjam M. Nordling-David, Doaa Jbara-Agbaria, Sandra Ciesek, Denisa Bojkova, Jindrich Cinatl, Anke Burger-Kentischer, Steffen Rupp, Andrea Zaliani, Thomas Grunwald, Philip Gribbon, Aimo Kannt, Gershon Golomb |
| 16 |
[GO] |
2023―Sep―09 |
Peptide delivery of a multivalent mRNA SARS-CoV-2 vaccine |
Cian M. McCrudden, Lindsey Bennie, Philip Chambers, Jordan Wilson, Megan Kerr, Monika Ziminska, Hayley Douglas, Sarah Kuhn, Emma Carroll, Garrett O'Brien, Niamh Buckley, Nicholas J. Dunne, Helen O. McCarthy |
| 17 |
[GO] |
2023―Jul―05 |
Characterization of stability, safety and immunogenicity of the mRNA lipid nanoparticle vaccine Iribovax® against COVID-19 in nonhuman primates |
Parvin Zamani, Mohammad Mashreghi, Mahere Rezazade Bazaz, Selma Zargari, Farzaneh Alizadeh, Mahyar Dorrigiv, Asghar Abdoli, Hossein Aminianfar, Mahdi Hatamipour, Javad Zarqi, Saeed Behboodifar, Yalda Samsami, Saeideh Khorshid Sokhangouy, Yahya Sefidbakht, Vuk Uskoković, Seyed Mahdi Rezayat, Mahmoud Reza Jaafari, Sina Mozaffari-Jovin |
| 18 |
[GO] |
2023―May―31 |
Plant-derived single domain COVID-19 antibodies |
Andrew M. Shen, Obeid M. Malekshah, Natalia Pogrebnyak, Tamara Minko |
| 19 |
[GO] |
2023―May―15 |
Antiviral polysaccharide and antiviral peptide delivering nanomaterials for prevention and treatment of SARS-CoV-2 caused COVID-19 and other viral diseases |
Shahin Homaeigohar, Xuan Liu, Mady Elbahri |
| 20 |
[GO] |
2023―Apr―30 |
Neutralisation of SARS-CoV-2 by monoclonal antibody through dual targeting powder formulation |
Han Cong Seow, Jian-Piao Cai, Harry Weijie Pan, Cuiting Luo, Kun Wen, Jianwen Situ, Kun Wang, Hehe Cao, Susan W.S. Leung, Shuofeng Yuan, Jenny K.W. Lam |
| 21 |
[GO] |
2023―Feb―17 |
Recent advances in respiratory immunization: A focus on COVID-19 vaccines |
Xiyue He, Xiaoyan Chen, Hairui Wang, Guangsheng Du, Xun Sun |
| 22 |
[GO] |
2023―Feb―08 |
Novel sialoglycan linkage for constructing adjuvant-protein conjugate as potent vaccine for COVID-19 |
Yu Wen, Ru-Yan Zhang, Jian Wang, Shi-Hao Zhou, Xiao-Qian Peng, Dong Ding, Zhi-Ming Zhang, Hua-Wei Wei, Jun Guo |
| 23 |
[GO] |
2023―Jan―13 |
Anti-PEG antibodies before and after a first dose of Comirnaty® (mRNA-LNP-based SARS-CoV-2 vaccine) |
Yaelle Bavli, Bing-Mae Chen, Guy Gross, Alon Hershko, Keren Turjeman, Steve Roffler, Yechezkel Barenholz |
| 24 |
[GO] |
2022―May―20 |
Nanoparticle-delivered TLR4 and RIG-I agonists enhance immune response to SARS-CoV-2 subunit vaccine |
Alexandra Atalis, Mark C. Keenum, Bhawana Pandey, Alexander Beach, Pallab Pradhan, Casey Vantucci, Laura O'Farrell, Richard Noel, Ritika Jain, Justin Hosten, Clinton Smith, Liana Kramer, Angela Jimenez, Miguel Armenta Ochoa, David Frey, Krishnendu Roy |
| 25 |
[GO] |
2022―Apr―27 |
COVID-19 inflammation and implications in drug delivery |
Makhloufi Zoulikha, Feifei Huang, Zhenfeng Wu, Wei He |
| 26 |
[GO] |
2022―Mar―30 |
Inhibition of SARS-CoV-2 replication in the lung with siRNA/VIPER polyplexes |
Domizia Baldassi, Shubhankar Ambike, Martin Feuerherd, Cho-Chin Cheng, David J. Peeler, Daniel P. Feldmann, Diana Leidy Porras-Gonzalez, Xin Wei, Lea-Adriana Keller, Nikolaus Kneidinger, Mircea Gabriel Stoleriu, Andreas Popp, Gerald Burgstaller, Suzie H. Pun, Thomas Michler, Olivia M. Merkel |
| 27 |
[GO] |
2022―Mar―28 |
Can pulmonary RNA delivery improve our pandemic preparedness? |
Olivia M. Merkel |
| 28 |
[GO] |
2022―Mar―21 |
mRNA vaccines for COVID-19 and diverse diseases |
Abid Hussain, Haiyin Yang, Mengjie Zhang, Qing Liu, Ghallab Alotaibi, Muhammad Irfan, Huining He, Jin Chang, Xing-Jie Liang, Yuhua Weng, Yuanyu Huang |
| 29 |
[GO] |
2022―Feb―03 |
Strategies for fighting pandemic virus infections: Integration of virology and drug delivery |
Takashi Nakamura, Norikazu Isoda, Yoshihiro Sakoda, Hideyoshi Harashima |
| 30 |
[GO] |
2021―Nov―20 |
Pulmonary surfactant as a versatile biomaterial to fight COVID-19 |
Lore Herman, Stefaan C. De Smedt, Koen Raemdonck |
| 31 |
[GO] |
2021―Aug―31 |
Nano-engineered tools in the diagnosis, therapeutics, prevention, and mitigation of SARS-CoV-2 |
Siya Kamat, Madhuree Kumari, C. Jayabaskaran |
| 32 |
[GO] |
2021―Jul―20 |
Repurpose but also (nano)-reformulate! The potential role of nanomedicine in the battle against SARS-CoV2 |
Salma N. Tammam, Sara El Safy, Shahenda Ramadan, Sita Arjune, Eva Krakor, Sanjay Mathur |
| 33 |
[GO] |
2021―Jun―25 |
Nanotechnology against COVID-19: Immunization, diagnostic and therapeutic studies |
Akbar Hasanzadeh, Masoomeh Alamdaran, Sepideh Ahmadi, Helena Nourizadeh, Mohammad Aref Bagherzadeh, Mirza Ali Mofazzal Jahromi, Perikles Simon, Mahdi Karimi, Michael R. Hamblin |
| 34 |
[GO] |
2021―Jun―24 |
Liposomal encapsulation of trans-crocetin enhances oxygenation in patients with COVID-19-related ARDS receiving mechanical ventilation |
Paul-Michel Mertes, Olivier Collange, Pierre Coliat, Mainak Banerjee, Marie-Charlotte Diringer, Anne Roche, Xavier Delabranche, Vitaliy Chaban, Manon Voegelin, Alexandre Bernard, Valérie Sartori, Nina Laurent, Michel Velten, Navreet Dhindsa, Jason Defuria, Gwangseong Kim, Zhenghong Hannah Xu, Marina Theodorou, Zhaohua Richard Huang, Kaniz Khalifa, Bolin Geng, Clet Niyikiza, Victor Moyo, Patrick Gizzi, Pascal Villa, Alexandre Detappe, Xavier Pivot |
| 35 |
[GO] |
2021―Jun―03 |
Tagged extracellular vesicles with the RBD of the viral spike protein for delivery of antiviral agents against SARS-COV-2 infection |
Yuxuan Fu, Sidong Xiong |
| 36 |
[GO] |
2021―May―21 |
The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2 |
Hai Huang, Caili Zhang, Shuping Yang, Wen Xiao, Qian Zheng, Xiangrong Song |
| 37 |
[GO] |
2021―Mar―30 |
The dawn of mRNA vaccines: The COVID-19 case |
Rein Verbeke, Ine Lentacker, Stefaan C. De Smedt, Heleen Dewitte |
| 38 |
[GO] |
2020―Dec―20 |
Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2 |
Kyung Soo Park, Joseph D. Bazzill, Sejin Son, Jutaek Nam, Seung Won Shin, Lukasz J. Ochyl, Jeanne A. Stuckey, Jennifer L. Meagher, Louise Chang, Jun Song, David C. Montefiori, Celia C. LaBranche, Janet L. Smith, Jie Xu, James J. Moon |
| 39 |
[GO] |
2020―Dec―02 |
Learning from past failures: Challenges with monoclonal antibody therapies for COVID-19 |
Samuel K. Lai, Morgan D. McSweeney, Raymond J. Pickles |
| 40 |
[GO] |
2020―Oct―07 |
Ivermectin: An award-winning drug with antiviral expectations against COVID-19 |
Fabio Rocha Formiga, Roger Leblanc, Juliana de Souza Rebouças, Leonardo Paiva Farias, Ronaldo Nascimento de Oliveira, Lindomar Pena |
| 41 |
[GO] |
2020―Aug―31 |
Nanotheranostics against COVID-19: From multivalent to immune-targeted materials |
Parichehr Hassanzadeh |
| 42 |
[GO] |
2020―Jul―03 |
Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? (*) |
Maurizio Muraca, Augusto Pessina, Michela Pozzobon, Massimo Dominici, Umberto Galderisi, Lorenza Lazzari, Ornella Parolini, Enrico Lucarelli, Giorgio Perilongo, Eugenio Baraldi |
|
